PALACOS® MV pro 80Recalls & reported problems
Heraeus Medical GmbH · The PALACOS® MV pro system consists of a mixing and application system prefilled with PALACOS® polymer powder and monomer liquid. PALACOS® MV pro is intended for use in arthroplastic procedures of the hip, knee, and other joints for the fixation of polymer or metallic prosthetic implants to living bone. · Class 2 · Implant
2 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 2
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04260102135369), received between Sep 10, 2024 and Sep 10, 2024 — classified as 1 malfunction.
2 FDA recall records name this device's identifier, 2 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Recalls naming this device
- Aug 20, 2026Open, Classified
Potential for monomer liquid leakage.
Z-3304-2026 · Root cause: Under Investigation by firm · FDA record ↗
- Dec 9, 2025Open, Classified
increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule breakage. An unfortunate combination of these influence factors can lead to unbreakable ampoules. If none or not all ampoules break, the product cannot be used on the patient since no or no appropriate cement dough is formed.
Z-1083-2026 · Root cause: Under Investigation by firm · FDA record ↗
Most reported problems
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 10, 2024
WHEN PREPARING THE CEMENT, THE LIQUID PORTION OF IT WOULD NOT TRANSFER TO THE POWDER. NEW CEMENT WAS OPENED AND USED; LOT NUMBER OF NEW CEMENT OPENED UNKNOWN. NO DELAY TO CASE OR HARM TO PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20180171 ↗
Other Bone Cement devices
- SMARTSET 3122-040Depuy (Ireland) · BONE CEMENT824 reports
- NA 3322-020Depuy (Ireland) · BONE CEMENT306 reports
- NA 3312-040Depuy (Ireland) · BONE CEMENT4 deaths258 reports
- NA 3332-040Depuy (Ireland) · BONE CEMENT4 deaths197 reports
- NA 5450-31-500Depuy (Ireland) · BONE CEMENT2 deaths168 reports
- NA 5450-32-500Depuy (Ireland) · BONE CEMENT1 death150 reports
- PALACOS® R pro 80Heraeus Medical GmbH · Bone Cement2 recalls1 report
- PALACOS® R pro 40Heraeus Medical GmbH · Bone Cement2 recalls0 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.